HIT Consultant June 6, 2024
Syed Hamza Sohail

What You Should Know:

AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel, virtual reality-based approach to medicine, today announced results from a secondary analysis of a large randomized controlled trial (RCT) that evaluated whether socio-demographic factors affected the clinical effectiveness of receiving a virtual reality (VR) therapy that treats chronic low back pain (cLBP) at home.

– Researchers sought to determine whether there were differences among key participant cohorts across patient-reported clinical effectiveness, therapeutic program engagement, and patient-reported VR device usability ratings.

RelieVRx: A Breakthrough in Pain Management Across Diverse Demographics

The study published in the Journal of Medical Extended Reality revealed that AppliedVR’s FDA-authorized RelieVRx device produced clinically effective results across various demographics, including age, gender, race/ethnicity,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Metaverse/VR, Patient / Consumer, Provider, Technology, Trends
Snap Spectacles 5 Redefine AR Glasses For Huge Developer Community
Roundtables: What’s Next for Mixed Reality: Glasses, Goggles, and More
Mark Zuckerberg On AI And The Magic Of The Metaverse
Apple Reportedly Weighing Smart Glasses Push
Combining VR and non-invasive brain stimulation to boost spatial memory without surgery

Share This Article